One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells. However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia (AML).
AML patients are often treated using allogeneic hematopoietic stem cell transplantation (allo-HCT), where they receive stem cells…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply